Patents : |  |
| US Patent No. | Title |
| 7582726 | VEGF receptor antagonists
|
| 7592332 | Cytokine inhibitors
|
| 7592342 | Quinoxaline derivatives as PI3 kinase inhibitors
|
| 7592422 | Modified plasminogen activator inhibitor type-1 and methods based thereon
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7595337 | Mitotic kinesin inhibitors
|
| 7595409 | 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
|
| 7597884 | Hyperglycosylated polypeptide variants and methods of use
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7598239 | Conjugated psychotropic drugs and uses thereof
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7592010 | Albumin fusion proteins
|
| 7589190 | Potent LNA oligonucleotides for the inhibition of HIF-1A expression
|
| 7585622 | Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
| 7585841 | Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
|
| 7585842 | Human kunitz-type inhibitor with enhanced antifibrinolytic activity
|
| 7585868 | Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists
|
| 7585888 | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
|
| 7588898 | Biomarker for gestational trophoblastic disease
|
| 7589068 | Inhibitors of Akt activity
|
| 7589098 | Methods and compositions utilizing quinazolinones
|
| 7589118 | IAP BIR domain binding compounds
|
| 7589119 | Methods for treating or preventing metastatic cancer using benzopyranone compounds
|
| 7598355 | Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
|
| 7599745 | Treating a tumor or the like with an electric field
|
| 7601359 | Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
|
| 7585997 | Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
|
| 7608408 | Methods of identifying compounds that inhibit Notch cleavage
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7608392 | Diagnostic assay for measuring a cell mediated immune response
|
| 7608260 | Stabilized immunoglobulins
|
| 7605266 | Azaindole inhibitors of Aurora kinases
|
| 7605236 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein
|
| 7601855 | Substituted chroman derivatives, medicaments and use in therapy
|
| 7604799 | EphA4 Antibodies
|
| 7605156 | Methods for the use of inhibitors of cytosolic phospholipase A2
|
| 7605167 | Use of cyclopamine in the treatment of psoriasis
|
| 7601700 | Modulation of eIF4E expression
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618631 | Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
|
| 7615628 | Imidazopyridine derivatives
|
| 7615208 | Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612032 | Method for treating oncological diseases
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
